NCT02804932

Brief Summary

The purpose of this study is to use a randomized, double-blind, placebo controlled study design to comprehensively investigate the impact of 8-weeks of dietary nitrate supplementation on skeletal muscle blood flow, mitochondrial function, and exercise capacity in patients with type 2 diabetes (T2D).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 17, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

August 15, 2016

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
4.4 years until next milestone

Results Posted

Study results publicly available

May 28, 2024

Completed
Last Updated

May 28, 2024

Status Verified

December 1, 2023

Enrollment Period

3.3 years

First QC Date

June 14, 2016

Results QC Date

March 1, 2023

Last Update Submit

December 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Maximal Exercise Capacity (VO2max)

    A 12-lead ECG, symptom limited cardiopulmonary exercise testing with gas exchange measurements will be performed on a cycle ergometer using a ramp protocol to determine maximal aerobic capacity (VO2max) and exercise efficiency.

    Pre and post 8 weeks of dietary nitrate supplementation

  • Change in Skeletal Muscle Perfusion During Exercise

    Forearm blood flow will be determined using Doppler ultrasound during rhythmic forearm exercise.

    Pre and post 8 weeks of dietary nitrate supplementation

  • Change in Skeletal Muscle Mitochondrial Function

    Muscle biopsies were obtained from the vastus lateralis using a Bergstrom needle with suction under local anesthesia, which will yield \~200-250mg of tissue. Mitochondrial function was assessed as follows: Fiber bundles were chemically permeabilized with saponin and mitochondrial respiration was analyzed by in situ high-resolution respirometry at 37°.

    Pre and post 8 weeks of dietary nitrate supplementation

Study Arms (2)

Beetroot crystals (nitrate)

EXPERIMENTAL

Participants will receive a nitrate rich beetroot powder (10g/day) for 8 weeks.

Dietary Supplement: Super Beets

Placebo (beetroot powder, no nitrate)

PLACEBO COMPARATOR

Participants will receive a beetroot powder placebo (no nitrate) for 8 weeks.

Other: Super Beets Placebo

Interventions

Super BeetsDIETARY_SUPPLEMENT

Nitrate rich beetroot powder (10g/day) for 8 weeks

Also known as: Beetroot crystals
Beetroot crystals (nitrate)

Nitrate deficient beetroot powder (10g/day) for 8 weeks

Also known as: Beetroot crystals no nitrate
Placebo (beetroot powder, no nitrate)

Eligibility Criteria

Age40 Years - 77 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
  • Age is \> or = 40 and \< or = 77 years of age
  • Documented Type 2 diabetes

You may not qualify if:

  • diagnosis of type 2 diabetes \< 3 years prior to enrollment
  • HbA1c \<6.0% or \>10.0%
  • body mass index \> 42 kg/m2
  • incident cardiovascular events in the last year (heart attack, stroke)
  • symptomatic coronary artery disease and/or heart failure
  • uncontrolled hypertension
  • hypotension (resting systolic BP \< 90 mmHg)
  • renal impairment with creatinine clearance (eGFR) of \<50 ml/min
  • smoking or history of smoking within past one year
  • use of medication which contain nitrates
  • use of anti-coagulant drugs
  • use of anti-platelet drugs
  • participation in research studies in which medications or interventions are given which would potentially alter subject responses in the current study
  • For 15 age- and weight-matched nondiabetic control subjects
  • Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
  • +13 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Related Publications (2)

  • Bock JM, Hanson BE, Miller KA, Seaberg NT, Ueda K, Feider AJ, Hanada S, Lira VA, Casey DP. Eight weeks of inorganic nitrate/nitrite supplementation improves aerobic exercise capacity and the gas exchange threshold in patients with type 2 diabetes. J Appl Physiol (1985). 2022 Dec 1;133(6):1407-1414. doi: 10.1152/japplphysiol.00478.2022. Epub 2022 Nov 3.

  • Bock JM, Hughes WE, Ueda K, Feider AJ, Hanada S, Casey DP. Dietary Inorganic Nitrate/Nitrite Supplementation Reduces Central and Peripheral Blood Pressure in Patients With Type 2 Diabetes Mellitus. Am J Hypertens. 2022 Sep 1;35(9):803-809. doi: 10.1093/ajh/hpac068.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

Final number of participants studied with muscle biopsies was smaller than the total number of subjects enrolled in the study. The lower number was influenced by: (i) subjects not consenting to the muscle biopsy procedure; or (ii) technical problems occurring in at least one of the testing visits (ex: not enough muscle tissue and/or extensive proportion of intramuscular fat obtained).

Results Point of Contact

Title
Dr. Darren Casey
Organization
University of Iowa

Study Officials

  • Darren P Casey, PhD

    University of Iowa

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 14, 2016

First Posted

June 17, 2016

Study Start

August 15, 2016

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

May 28, 2024

Results First Posted

May 28, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations